Cubist Systematic Strategies, LLC Takeda Pharmaceutical CO LTD Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.89 - $15.04 $944 - $1,022	68 New	68 $0
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $1.4 Million - $1.53 Million	-89,642 Reduced 99.94%	58 $0
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $420,368 - $453,381	27,511 Added 44.24%	89,700 $1.48 Million
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $406,841 - $511,664	32,757 Added 111.3%	62,189 $970,000
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $1.06 Million - $2.38 Million	-83,010 Reduced 73.82%	29,432 $382,000
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $665,197 - $762,036	50,701 Added 82.12%	112,442 $1.58 Million
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $1.34 Million - $1.52 Million	-98,995 Reduced 61.59%	61,741 $884,000
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $1.61 Million - $2 Million	122,032 Added 315.3%	160,736 $2.19 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $389,341 - $412,272	-23,886 Reduced 38.16%	38,704 $634,000
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $1.33 Million - $1.5 Million	-80,657 Reduced 56.31%	62,590 $1.05 Million
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $1.62 Million - $1.93 Million	96,771 Added 208.22%	143,247 $2.62 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $213,951 - $263,720	-13,902 Reduced 23.02%	46,476 $846,000
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $447,609 - $502,317	-26,176 Reduced 30.24%	60,378 $1.08 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $783,410 - $1.05 Million	53,695 Added 163.41%	86,554 $1.55 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $106,086 - $165,485	-8,148 Reduced 19.87%	32,859 $499,000
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $577,633 - $712,802	34,220 Added 504.2%	41,007 $809,000
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $650,425 - $724,529	-40,274 Reduced 85.58%	6,787 $117,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $89,913 - $111,117	-5,423 Reduced 10.33%	47,061 $833,000
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $876,482 - $1.13 Million	52,484 New	52,484 $1.07 Million

Others Institutions Holding TAK

# of Institutions

320

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$182 Million
0.04% of portfolio
Mondrian Investment Partners LTD London, X0

7.74M
Shares

$107 Million
1.74% of portfolio
Morgan Stanley New York, NY

4.99M
Shares

$69.1 Million
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.35M
Shares

$60.2 Million
0.03% of portfolio
Goldman Sachs Group Inc New York, NY

3.72M
Shares

$51.5 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account